Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -738,822 | -846,422 | -408,168 | -570,279 | -213,796 |
| Depreciation Amortization | 9,922 | 7,855 | 6,912 | 1,386 | 1,393 |
| Accounts payable and accrued liabilities | -6,386 | 710 | 4,874 | 5,928 | 1,025 |
| Other Working Capital | 1,357 | 16,811 | 24,613 | -28,604 | 1,664 |
| Other Operating Activity | 124,491 | 238,593 | 40,044 | 293,880 | 63,874 |
| Operating Cash Flow | $-609,438 | $-582,453 | $-331,725 | $-297,689 | $-145,840 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -715 | -4,049 | -3,048 | -6,074 | -938 |
| Net Acquisitions | N/A | 391 | N/A | -35,000 | 1,882 |
| Purchase Of Investment | -266,875 | -745,680 | -194,121 | -259,716 | N/A |
| Sale Of Investment | 570,000 | 504,364 | 326,999 | 0 | N/A |
| Other Investing Activity | -1,849 | 0 | 0 | -4,000 | 0 |
| Investing Cash Flow | $300,561 | $-244,974 | $129,830 | $-304,790 | $944 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 250,000 | 0 | 0 | N/A | N/A |
| Common Stock Issued | 191,008 | 677,666 | 247,920 | 284,255 | 395 |
| Other Financing Activity | -1,891 | 108 | -36,012 | 483,342 | 138,052 |
| Financing Cash Flow | $439,117 | $677,774 | $211,908 | $767,597 | $138,447 |
| Exchange Rate Effect | -3 | 75 | -497 | 429 | N/A |
| Beginning Cash Position | 102,542 | 252,120 | 242,604 | 77,057 | 83,506 |
| End Cash Position | 232,779 | 102,542 | 252,120 | 242,604 | 77,057 |
| Net Cash Flow | $130,237 | $-149,578 | $9,516 | $165,547 | $-6,449 |
| Free Cash Flow | |||||
| Operating Cash Flow | -609,438 | -582,453 | -331,725 | -297,689 | -145,840 |
| Capital Expenditure | -715 | -4,049 | -3,048 | -6,074 | -938 |
| Free Cash Flow | -610,153 | -586,502 | -334,773 | -303,763 | -146,778 |